Dry eye sufferers may now consider LASIK procedure

New Orleans-Cyclosporine 0.05% ophthalmic emulsion (Restasis, Allergan) appears to be safe and effective in enhancing clinical outcomes in patients with dry eye who wish to undergo LASIK, said George M. Salib, MD.

Related Videos

Related Content

Advertisement

March 18th 2025

HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 17th 2025

Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 17th 2025

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study

March 17th 2025

Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025

Related Content

Advertisement

March 18th 2025

HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 17th 2025

Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 17th 2025

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study

March 17th 2025

Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025